gb3226
·Code: BRM-1420
gb3226: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Damora Therapeutics, Inc. (DMRA) | Preclinical |
Get deeper analysis on gb3226
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis